Equillium, Inc. (EQ)
2.20
-0.11
(-4.76%)
USD |
NASDAQ |
Aug 24, 16:00
2.24
+0.04
(+1.82%)
After-Hours: 20:00
Equillium Enterprise Value : 82.92M for Aug. 24, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| August 24, 2026 | 82.92M |
| August 21, 2026 | 89.89M |
| August 20, 2026 | 87.36M |
| August 19, 2026 | 91.16M |
| August 18, 2026 | 92.43M |
| August 17, 2026 | 100.67M |
| August 14, 2026 | 93.06M |
| August 13, 2026 | 70.87M |
| August 12, 2026 | 81.65M |
| August 11, 2026 | 84.82M |
| August 10, 2026 | 82.28M |
| August 07, 2026 | 77.21M |
| August 06, 2026 | 77.85M |
| August 05, 2026 | 82.28M |
| August 04, 2026 | 86.72M |
| August 03, 2026 | 82.92M |
| July 31, 2026 | 82.92M |
| July 30, 2026 | 90.53M |
| July 29, 2026 | 87.99M |
| July 28, 2026 | 90.53M |
| July 27, 2026 | 99.40M |
| July 24, 2026 | 101.31M |
| July 23, 2026 | 113.99M |
| July 22, 2026 | 118.43M |
| July 21, 2026 | 110.18M |
| Date | Value |
|---|---|
| July 20, 2026 | 100.04M |
| July 17, 2026 | 107.65M |
| July 16, 2026 | 101.94M |
| July 15, 2026 | 109.55M |
| July 14, 2026 | 118.43M |
| July 13, 2026 | 126.04M |
| July 10, 2026 | 127.94M |
| July 09, 2026 | 131.11M |
| July 08, 2026 | 143.16M |
| July 07, 2026 | 126.04M |
| July 06, 2026 | 119.06M |
| July 02, 2026 | 127.94M |
| July 01, 2026 | 136.18M |
| June 30, 2026 | 146.33M |
| June 29, 2026 | 134.11M |
| June 26, 2026 | 132.21M |
| June 25, 2026 | 125.89M |
| June 24, 2026 | 119.57M |
| June 23, 2026 | 118.93M |
| June 22, 2026 | 120.20M |
| June 18, 2026 | 132.21M |
| June 17, 2026 | 128.42M |
| June 16, 2026 | 113.24M |
| June 15, 2026 | 116.40M |
| June 12, 2026 | 117.04M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Ironwood Pharmaceuticals, Inc. | 1.000B |
| Fortress Biotech, Inc. | -3.710M |
| Cue Biopharma, Inc. | 112.63M |
| Legend Biotech Corp. | 3.371B |
| Dianthus Therapeutics, Inc. | 5.146B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -4.693M |
| Total Expenses (Quarterly) | 4.693M |
| EPS Diluted (Quarterly) | -0.042 |
| Earnings Yield | -9.23% |
| Normalized Earnings Yield | -9.227 |